drugset / Trial / NCT00883935
GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to compare the amount of GSK1349572 (study drug) in the blood when given with and without atazanavir/ritonavir or atazanavir and to compare the blood levels of atazanavir when given with GSK1349572 to historical data for atazanavir.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | 300 mg | — |
| Subject | Atazanavir | Other / unclassified | 400 mg | — |
| Subject | Dolutegravir | Other / unclassified | 30 mg | — |
| Subject | Ritonavir | Other / unclassified | 100 mg | — |
Indications
No indication recorded.